11th DNDi Partners’ Meeting celebrates African leadership in innovation for R&D and access to medicines
11th DNDi Partners’ Meeting celebrates African leadership in innovation for R&D and access to medicines
Meeting opened by Ugandan Prime Minister convenes public & private sector partners from more than 40 countries   On 4 October 2018, DNDi held its 11th Partners’ Meeting in Kampala, Uganda. The meeting gathered together more than 400 partners and stakeholders from over 150 institutions and more than 40 countries, primarily African.
11th DNDi Partners’ Meeting celebrates African leadership in innovation for R&D and access to medicines
Joelle Tanguy appointed Director of External Relations at DNDi
Joelle Tanguy appointed Director of External Relations at DNDi
DNDi is very pleased to announce the appointment of Joelle Tanguy as Director of External Relations and a member of the organization’s Executive Team.
Joelle Tanguy appointed Director of External Relations at DNDi
Inaugural DNDi training for health & science journalists in Kampala
Inaugural DNDi training for health & science journalists in Kampala
In early October, 18 journalists from 11 African countries converged in Kampala, Uganda for DNDi’s first-ever training on health and science journalism. The three-day training was conducted during a week of workshops and meetings related to the work of DNDi and its many partners, culminating in the 11th DNDi Partners’ Meeting on 4 October 2018.
Inaugural DNDi training for health & science journalists in Kampala
New hope for PKDL patients in Africa as clinical trial aims to make treatment safer and easier
New hope for PKDL patients in Africa as clinical trial aims to make treatment safer and easier
Nairobi/Khartoum - 12 September 2018 Trial to take place in Sudan, which has the world’s highest rates of this highly stigmatizing disease A clinical trial to find a better treatment for severe or chronic cases of post kala-azar dermal leishmaniasis (PKDL) in Africa has begun in Dooka, Sudan. The objective of this clinical trial, which is being conducted by the DNDand the Institute for Endemic Diseases at the University of Khartoum, is to shorten the length of hospitalization for PKDL, and deliver a treatment that is safer to use and easier to administer.
New hope for PKDL patients in Africa as clinical trial aims to make treatment safer and easier
See all news

Scientific Articles

See all scientific articles

Events

  • Keystone Conference 2018

    21st Century Drug Discovery and Development for Global Health

    17-20 October 2018 Berlin, Germany
    • Nathalie Strub-Wourgaft, NTD Director - presentation on the new therapies for sleeping sickness
    • Charles Mowbray, Discovery Director - presentation on new orally active treatments for leishmaniasis
  • COR-NTD Annual Meeting 26-27 October 2018 New Orleans, USA
    • Sergio Sosa-Estani, Head of Chagas Clinical Program, and Andrea Marchiol, Chagas Access Project Manager - session on control and care of Chagas disease in health networks
    • Suman Rijal, Head Regional Office, DNDi India - presentation on VL/HIV co-infections and PKDL
  • ASTMH 2018

    67th Annual Meeting

    28 October - 1 November 2018 New Orleans, USA
    • Nathalie Strub-Wourgaft, NTD Director - presentation on fexinidazole in a symposium on sleeping sickness elimination
    • Colin Forsyth, Chagas Epidemiologist, Sergio Sosa Estani, Head of Chagas Clinical Programme, Eric Chatelain, Head of Drug Discovery Programme - symposium on screening and diagnosis of Chagas disease
    • Poster and oral presentations on sleeping sickness, visceral leishmaniasis, Chagas, onchocerciasis, and mycetoma
  • International Conference on Innovations for the Elimination and Control of Visceral Leishmaniasis (IEC-VL) 28-30 November 2018 New Delhi, India
    • DNDi is a co-organizer of the event - session on visceral leishmaniasis and PKDL about diagnostics, treatments, and elimination
See all events